Supramolecular nanogels based on gelatin-cyclodextrin-stabilized silver nanocomposites with antibacterial and anticancer properties.

An effective method for reducing silver ions using gelatin (Gel) and 2-hydroxypropyl-ß-cyclodextrin (HPCD) hydrogels, which stabilize silver at various concentrations is described. The formation of AgNPs in solution, as well as Gel-HPCD nanogels, is confirmed by the surface plasmon resonance (SPR) band at 420-440 nm in the UV-Vis spectrum. The resulting Gel-HPCD and Gel-HPCD/AgNPs composites are characterized using various techniques, including scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), X-ray diffractometry (XRD), and thermogravimetric analysis (TGA). SEM images showed that the porous structure and the AgNPs are homogeneously dispersed throughout the Gel-HPCD/AgNP composites network. The AgNPs in the Gel-HPCD/AgNPs composite is crystalline, with spherical particles having an average size of 7.0 ± 2.5 nm, as determined by TEM. The Gel-HPCD/AgNPs composites are strongly effective against both gram-positive (Staphylococcus aureus) and gram-negative (Escherichia coli) bacteria. The assembled antibacterial Gel-HPCD/AgNPs composites are also assessed for their cytotoxic and anticancer activities using HCT-116 cancer cells. The results suggest that Gel-HPCD/AgNPs composites could be used as effective therapeutics in the future in tissue engineering applications, as their bactericidal properties and low toxicity make them ideal for clinical use.

The anti-biofilm and anti-virulence activities of trans-resveratrol and oxyresveratrol against uropathogenic Escherichia coli.

Uropathogenic Escherichia coli (UPEC) is the primary causative agent of urinary tract infections, which are one of the most common infectious disease types in humans. UPEC infections involve bacterial cell adhesion to bladder epithelial cells, and UPEC can also form biofilms on indwelling catheters that are often tolerant to common antibiotics. In this study, the anti-biofilm activities of t-stilbene, stilbestrol, t-resveratrol, oxyresveratrol, ε-viniferin, suffruticosol A, and vitisin A were investigated against UPEC. t-Resveratrol, oxyresveratrol, and ε-viniferin, suffruticosol A, and vitisin A significantly inhibited UPEC biofilm formation at subinhibitory concentrations (10-50 µg ml-1). These findings were supported by observations that t-resveratrol and oxyresveratrol reduced fimbriae production and the swarming motility in UPEC. Furthermore, t-resveratrol and oxyresveratrol markedly diminished the hemagglutinating ability of UPEC, and enhanced UPEC killing by human whole blood. The findings show that t-resveratrol, oxyresveratrol, and resveratrol oligomers warrant further attention as antivirulence strategies against persistent UPEC infections.